VWR acquires Purification Technologies

Published: 8-Oct-2015
Ingredients Finance

Enhances high purity product portfolio


VWR, a provider of laboratory products, services and solutions, has acquired Purification Technologies Inc (PTI), to enhance its growing laboratory and production chemical manufacturing portfolio.

Purification Technologies, based in Chester, Connecticut, US, is a speciality solvent company that produces high purity solvents for analystical, biotechnology and agrochemical customers internationally.

'PTI's solvent purification expertise and process capabilities improve access to a key solvent line and enhances our portfolio of high purity products available to our customers,' said Manuel Brocke-Benz, President and CEO of VWR.

'Our customers in the chromatography, biochemical and agrochemical industries will benefit through VWR's ability to supply high purity Acetonitrile and other solvents in both bulk and lab scale quantities.'

No financial details have been revealed about the deal.

  • Companies:
  • Avantor Sciences
See more

You may also like

Media

Avantor and GeminiBio embark on partnership for bioproduction workflow solutions

Read more
The two US-based companies have entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. Mastering modified-release performance: excipient considerations Imagine a world where enhanced therapeutic efficacy, improved patient compliance and reduced adverse effects are tangible outcomes — even for drugs with short pharmacokinetic (PK) half-lives or narrow therapeutic indices. This is becoming a reality with modified-release (MR) oral delivery systems such as hydrophilic matrix tablets
  4. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  5. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Media

Avantor and GeminiBio embark on partnership for bioproduction workflow solutions

The two US-based companies have entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry
Manufacturing

Avantor and Cytovance collaborate on plasmid DNA supply

The collaboration extends Avantor’s offering of critical materials for vaccines and therapeutics focused on cell and gene therapy
Finance

Avantor completes acquisition of Masterflex

Based in Illinois, Masterflex manufactures of peristaltic pumps and aseptic single-use fluid transfer technologies
Finance

Avantor expands China footprint with RIM Bio acquisition

The manufacturer’s Changzhou, China facility will be Avantor's first single-use production plant in the AMEA region
Media

Avantor completes acquisition of VWR

Avantor, a global supplier of ultra-high-purity materials for the life sciences and advanced technology industries, announced the successful completion of its acquisition of VWR Corporation, an independent provider of product, supply chain and service solutions, for laboratory and production customers
Manufacturing

Avantor to begin cGMP production of J.T.Baker high purity low endotoxin sugars in Panoli, India

Avantor is unique in offering cGMP manufacturing capabilities in the US, Europe and India
Ingredients

Merger of Avantor Performance Materials and NuSil Technology completed

Merger creates global leader in life science and advanced technology materials
Subscribe now